No abstract available
Keywords:
Acute coronary syndromes; Dual antiplatelet therapy; P2Y12 receptor inhibitors; Platelets.
MeSH terms
-
Acute Coronary Syndrome / drug therapy*
-
Aged
-
Aged, 80 and over
-
Clopidogrel / therapeutic use
-
Dual Anti-Platelet Therapy / adverse effects
-
Dual Anti-Platelet Therapy / methods*
-
Female
-
Glomerular Filtration Rate
-
Hemorrhage / chemically induced
-
Humans
-
Male
-
Platelet Aggregation Inhibitors / administration & dosage
-
Platelet Aggregation Inhibitors / adverse effects
-
Platelet Aggregation Inhibitors / therapeutic use*
-
Prasugrel Hydrochloride / therapeutic use
-
Purinergic P2Y Receptor Antagonists / administration & dosage
-
Purinergic P2Y Receptor Antagonists / adverse effects
-
Purinergic P2Y Receptor Antagonists / therapeutic use*
-
Randomized Controlled Trials as Topic
-
Ticagrelor / therapeutic use
Substances
-
Platelet Aggregation Inhibitors
-
Purinergic P2Y Receptor Antagonists
-
Clopidogrel
-
Prasugrel Hydrochloride
-
Ticagrelor